SERN | Southeast NBS & Genetics Regional Collaborative

Like us on Facebook! Follow SERC_Genetics on Twitter Subscribe to our RSS Feed
Login | Contact Us

COVID-19 is an emerging, rapidly evolving situation.

Recommendations for the Nutrition Management of Phenylalanine Hydroxylase Deficiency - Amy Cunningham MS, RD, LDN
Recommendations for the Nutrition Management of Phenylalanine Hydroxylase Deficiency  
2014 SERC-SERGG Annual Conference
University of Florida Health
Pediatric Specialties
Tallahassee, FL  
July 17th, 2014

About the Presentation
Presenter Biography
Amy Cunningham is the senior Metabolic Nutritionist with the Hayward Genetics Center at Tulane University School of Medicine. She is a Licensed and Registered Dietitian and holds an MS in nutrition with a minor in biochemistry. As part of the Tulane clinical genetics team, she coordinates dietary treatment for children and adults with inherited metabolic disease, and participates in Hayward research projects and teaching programs. Amy is a Founding Board member, and Past President of Genetic Metabolic Dietitians International (GMDI). She is co-chair of the PKU Workgroup for the joint GMDI and SERC Genetics and Newborn Screening Collaborative project to develop evidenced-based treatment guidelines for metabolic diseases. She is a past board member of the Southeastern Regional Genetics Group (SERGG), a member of the Society for Inherited Metabolic Disorders (SIMD), and is past chair of the ADA specialty practice group for inborn errors of metabolism. She has contributed to initiatives at the federal level: a NORD/GMDI effort to enhance access to metabolic treatment components, an ACMG workgroup to develop ACT Sheets for age transitioning patients, and an NIH review of the state of the science in PKU. She sits on advisory boards for BioMarin and Merck pharmaceutical companies.

Selected Publications by the Presenter
Cunningham A, Bausell H, Brown M, Chapman M, DeFouw K, Ernst S, McClure J, McCune H, O'Steen D, Pender A, Skrabal J, Wessel A, Jurecki E, Shediac R, Prasad S, Gillis J, Cederbaum S. Recommendations for the use of sapropterin in phenylketonuria. Mol Genet Metab. 2012 Jul;106(3):269-76. doi: 10.1016/j.ymgme.2012.04.004. Epub 2012 Apr 13.PMID:22575621   Bettiol,E, Marant,C, Burlna,A, Cunningham, A, Gasteyger,C, Benmedjahed,K, Abetz,L, Champigneulle,A: International Development of Disease-specific Questionnaires to Assess the Impact of Phenylketonuria and Its Treatment on Daily Life: Qualitative Steps. Poster presentation at 2010 SSIEM conference, Istanbul, Turkey   Cunningham,A, Pridjian,G, Andersson,HC: PKU Treatment With Tetrahydrobiopterin (Sapropterin) During Pregnancy. Poster presentation, American Society of Human Genetics conference 2008, updated at International Congress of Inborn Errors of Metabolism, 2009.

Home | About | Contact Us
This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $600,000.00 with 0 percent financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit